Immunovant, Inc. (IMVT) Q1 2025 Annual Earnings
IMVT·Reported May 29, 2025·Before market open
Diluted EPS came in at $-0.64 (-23.1% YoY), beat the $-0.71 consensus by $0.07.
Diluted EPS
$-0.64beat by $0.07
Consensus: $-0.71
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Immunovant, Inc.'s Q1 2025 earnings report.
Immunovant, Inc. (IMVT) reported Q1 2025 earnings on May 29, 2025 before market open.
Immunovant, Inc. reported diluted EPS of $-0.64 for Q1 2025.
EPS beat the consensus estimate of $-0.71 by $0.07.
Compared to the same quarter a year prior, diluted EPS declined 23.1% from $-0.52.
You can read the 10-K periodic report (0001764013-25-000092) directly on SEC EDGAR. The filing index links above go to sec.gov.